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Summary 
We used surface plasmon resonance to study the bind- 
ing of a set of soluble mouse I-E class II major histo- 
compatlblllty molecules, each occupied by a different 
single peptide, to the staphylococcal enterotoxin su- 
perantlgens, SEA and SEB. The rates of association 
and dissociation to SEA varied greatly depending on 
the I-E-bound peptlde. By contrast, binding to SEB 
yielded fast association and dissociation rates, which 
were relatively peptlde independent. The results also 
indicated nonoverlapping binding sites for SEB and 
SEA on class II and raised the possibility of enhanced 
SAg presentation to T cells by cross-linking of cell sur- 
face class II. 
Introduction 
The class I and class II molecules of the major histocom- 
patibility complex (MHC) present peptide fragments of an- 
tigens to T cells. Recognition of these peptide-MHC li- 
gands by T cell a8 receptors involves the regions of the 
Vu and VP portions of the receptor, which are homologous 
to the complementarity-determining regions of immuno- 
globulins (reviewed by Davis and Bjorkman, 1968). Class 
II molecules also present a set of microbial proteins called 
superantigens (SAgs) to T cells (Marrack and Kappler, 
1990; Kotzin et al., 1993; Scherer et al., 1993). These 
include the staphylococcal enterotoxins, such as SEA and 
SEB. T cells recognize SAg-class II complexes via their 
a8 receptors. However, in this case, the specificity of the 
interaction is controlled almost entirely by an area of the 
V6 element of the receptor not involving the complemen- 
tarity-determining regions (Pullen et al., 1990; Choi et al., 
1990; Cazenave et al., 1990), with each SAg specific for 
a distinct set of Vj3 elements (Kappler et al., 1987, 1988, 
1989; Whiteet al., 1989). BecauseTcellsexpressalimited 
number of Vj3 elements, an individual SAg activates a 
much higher proportion of total T cells than do conven- 
tional peptide antigens. Paradoxically, the flood of cyto- 
tPresent address: Department of Molecular Microbiology and Immu- 
nology, Oregon Health Science University, Portland, Oregon 97221 
kines and cell activation accompanying this very strong 
immune response plays a role in the pathology of the or- 
ganisms that produce SAgs (Marrack et al., 1990; Kotzin 
et al., 1993). 
The way in which SAgs specifically bridge a8 receptors 
to class II molecules is being revealed by the combination 
of biochemical, genetic, and crystallographic studies. The 
precise interaction sites between SAgs and class II have 
not been defined completely, but the evidence suggests 
that the interactions involve a site different from the highly 
polymorphic peptide-binding groove. For example, SEB 
has a two-domain structure (Swaminathan et al., 1992). 
A major SEB interaction with human class II is between 
amino acids in a hydrophobic 6 barrel contained in the 
SEB N-terminal domain with the al domain the class II 
molecule (Kappler et al., 1992; Jardetzky et al., 1994). 
Since SEA and SEB are quite related, one might predict 
that SEA and SEB would bind to class II similarly. Indeed, 
SEA competes with SEB for binding to class II (Fraser, 
1989, Thibodeau et al., 1994a). However, unlike SEB, SEA 
binding is dependent on a Zn*+ cation incorporated into 
the C-terminal domain of SEA predicted to be on the oppo- 
site side of the molecule from this hydrophobic site (Fraser 
et al., 1992; Hudson et al., 1995). Furthermore, a histidine 
at position 81 of the class II 61 domain a helix has been 
shown to be essential for high affinity binding of SEA (Her- 
man et al., 1990, 1991; Jorgensen et al., 1992) and may 
operate by providing an additional coordination group for 
the Zn*+ of SEA. This raises the possibility that the primary 
site of SEA binding to class II is distinct from that of SEB. 
We studied this question with a set of soluble mouse 
I-E class II molecules, each of which contained a single 
antigenic peptide covalently attached via a flexible linker 
to the N terminusofthepchain(Kozonoet al., 1994). Using 
surface plasmon resonance, we examined their ability to 
bind to SEA and SEE. Our results show that the primary 
interaction site on these class II molecules for SEA is non- 
overlapping with that of SEB and raise the possibility that 
during presentation to T cells, these toxin superantigens 
may cross-link class II molecules. 
Results 
Soluble Class II Constructs 
Using the baculovirus system (Stern and Wiley, 1992), we 
produced a series of soluble I-Edk class II molecules, each 
of which carried asingle covalently bound peptide(Kozono 
et al., 1994) (Table 1). The peptides included three well- 
characterized ones from moth cy-tochrome C (MCC) and 
pigeon cytochrome C (PCC) (reviewed by Jorgensen et al., 
1992): MCC(91-103), a mutant form of the MCC peptide, 
MCC(Sl-103, K99A) and a mutant form of the equivalent 
peptide from PCC(Sl-104, T102S). These mutations af- 
fect T cell recognition rather than peptide binding to class 
II. Additional peptides included another well-characterized 
one from the 6 allele of the mouse hemoglobin 3 chain, 
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Hb(64-76), which is immunogenic in mice carrying other 
hemoglobin alleles (Lorenz and Allen, 1968), and a mutant 
of this peptide, Hb(64-76, N72A). This amino acid muta- 
tion again has been reported to affect Tcell receptor (TCR) 
recognition, but not class II binding (Evavold et al., 1993). 
Finally, an I-Ek binding peptide from mouse heat shock 
protein 70, Hsp70(236-248), was chosen (Marrack et al., 
1993). 
Binding of SEA and SEB to I-EL and I-Edr’ 
To study directly the interaction of these soluble class II- 
peptide complexes with SAgs and monoclonal antibodies 
(MAbs) we used the BlAcore system, which makes use 
of the principal of surface plasmon resonance toquantitate 
the kinetics of the binding of a mobile phase protein to 
another, which has been immobilized in the flow cell of a 
biosensor chip (see Experimental Procedures). In an initial 
experiment, we examined the ability of I-E*-Hb in the mo- 
bile phase to bind to immobilized SEA or SEB. The results 
of a typical experiment are shown in Figure 1A. 
Soluble I-Edk-Hb bound well to SEA, but very poorly to 
SEB. The better binding of SEB to human rather than 
mouse class II has been noted previously (Mollick at al., 
1991). Several amino acids unique to human DR and im- 
portant for the binding of SEB have been located on a 
loop of the class II a chain between p strands 3 and 4 
(Thibodeau et al., 1994a, 1994b; Jardetzky et al., 1994). 
Therefore, in an effort to produce versions of our soluble 
I-Edk molecules that bound better to SEB, we altered the 
a chain in some of them by changing three amino acids 
(136, E37, S39) on this loop to the corresponding DR amino 
acids (M, A, K) (see Table 1; Experimental Procedures). 
These proteins are referred to below as I-Edrdk. 
The binding of I-Edrdk-Hb to SEA and SEB is shown in 
Figure 1 B. Introduction of the a chain HLA-DR amino acids 
had no effect on the binding to SEA, but dramatically im- 
proved the binding to SEB, confirming the influence of this 
region of class II in SEB binding. As a specificity control, 
we tested the ability of I-Edrdk-Hb to bind to SEB carrying 
the mutation F44S, which has been shown to reduce se- 
verely binding to class II (Kappler et al., 1992). As pre- 
dicted, we saw no detectable binding of I-Edrdk-Hb to this 
mutant SEB. 
The kinetics of the interactions between these class II 
molecules and SEA or SEB were very different. The data 
for SEA matched well single binding site kinetics, from 
which we calculated association and dissociation rates 
(Table 2) (see Experimental Procedures). The association 
rates for binding of I-Edk-Hb and I-Edrdk-Hb to SEA were 
similarly, surprisingly slow (<lo4 I/mol/s). Since diffusion- 
limited interactions of proteins can achieve association 
rates well in excess of lo5 I/mol/.s, these results indicate 
that diffusion is probably not the limiting step in class II 
binding to SEA, possibly because of a requirement for a 
relatively disfavored conformational change in either SEA 
or class II molecule prior to binding. The SEA/I-Edk-Hb 
and SEA/I-Edrdk-Hb complexes both dissociated at a rate 
of about 2 x lo-% for a half-life of 8-10 min (Table 2). 
The results with I-Edrdk-Hb binding to SEB were very 
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Figure 1. Binding of Soluble I-Ed’ Molecules to SEA and SE6 
SEA, SEB, and SEB(F44S) were immobilized in three biosenser flow 
cells to a level of 3500,3400, and 5400 RU, respectively. In (A), soluble 
I-E”-Hb (1 PM) was injected for 3 min (flow rate, 10 ullmin) into the 
SEA and SEB flow cells and the binding kinetics recorded during the 
association and dissociation phase. In (6). soluble I-EdrV-fb was 
injected into all three flow cells under the same conditions. The data 
are presented as RU versus time with the RU value of the flow cell 
with the immobilized SAg and running buffer only set to zero. 
different. In this case, a fast association rate of - lo5 II 
mo9.s was seen. The dissociation data for SEB did not 
match single exponential decay kinetics very well. The 
majority of the class II dissociated very rapidly, with a rate 
of 3.5 x 10% for a half-life of less than 30 s. However, 
a small portion of the class II dissociated from the SEB 
very slowly. We are not yet able to judge the biological 
significance of this residual binding. It may indicate a low 
level of a meaningful slower second order reaction; for 
example, a conformational change in the initial interaction 
site or bivalent binding of one class II to two SEB molecules 
via a second interaction site (see Discussion). For the 
faster dissociating component, an apparent dissociation 
constant of 0.3 f&l can be estimated. Thus, while the SEA- 
class II and SEB-class II showed similar dissociation con- 
stants, these were achieved via very different kinetics. 
In this and the subsequent experiments presented be- 
low, the SAgs were immobilized in the Biosenser flow cell 
and the peptide-class II complexes were introduced in 
the mobile phase, because the bacterial SAgs survived 
multiple rounds of binding and dissociation better than 
did the class II molecules. Virtually identical kinetics were 
obtained in a few experiments performed in reverse with 
the class II-peptide immobilized and the SAgs in the mo- 
bile phase (data not shown). 
Peptide Influences on SEA, but not SEB Binding 
to Class II 
Studies have shown that xenotypic, allelic, and isotypic 
variants of class II molecules differ in their abilities to bind 
SEA and SEB (Herrmann et al., 1989; Herman et al., 1990; 
Scholl et al., 1990; Mollick et al., 1991). In general, these 
differences have been attributed to amino acid variations 
outside of the antigen-binding groove and, in the recent 
crystallographic study of SEB bound to the human class 
II molecule, DRl , there were no apparent direct contacts 
between the class II-bound peptide and SEB (Jardetzky 
at al., 1994). However, there is some indirect evidence 
that the class II peptide may influence binding of SEA and 
SEB. Mutations in DR in the peptide-binding groove or 
DR expression in different cell types can influence SEB 
presentation (Thibodeau et al., 1994a). Also, the accessi- 
bility to biotinylated class II-bound peptides to avidin can 
be reduced by the binding of SEA (Dowd et al., 1995). 
The set of I-Edk and I-Edrdk molecules occupied by differ- 
ent peptidesgaveusauniquetool toexaminethisquestion 
directly. Therefore, we studied the binding of the I-Edk mol- 
ecules to SEA and the I-Edrdk molecules to SEB. The re- 
sults, presented in Figure 2 and Table 3, showed that the 
particular peptide bound to I-Edk had a profound effect on 
its binding to SEA, but not to SEB. 
For SEA, three binding patterns were seen with the most 
dramatic effect of the peptide on dissociation rates. The 
strongest binding to SEA was seen with I-Edk containing the 
MCC peptide or either of the two closely related peptides, 
MCCK99A and PCCT102S (Figure 2A). All three class 
II molecules bound to SEA with similar kinetics. As seen 
before with I-Edk-Hb, their association rates were very slow 
at 8-9 x IO3 I/mol/s. However, in this case dissociation 
rates for all three were also very slow at 2-4 x lo-‘Ys 
for a half-life of about 1 hr and an apparent dissociation 
constants of 0.03-0.08 PM. 
The results for I-Edk-Hb binding to SEA (Figure 28) were 
similar to those shown in Figure 1, a slow association rate 
of 3 x lo3 llmolls with an intermediate dissociation rate of 
1.7 x 1 Oe3/s for a half-life of about 10 min and an apparent 
dissociation constant of 0.5 PM. An amino acid substitu- 
tion in the C-terminal half of the Hb peptide (N72A) had 
very little effect on the binding kinetics. 
The poorest binding to SEA was seen with I-Edk-Hsp70 
(Figure 2C). Its dissociation rate of (1.9 x 10%) was 
approximately ten times faster than that of I-Edk-Hb and 
approximately one hundred times faster than that of I-Edk- 
MCC for a half-life of less than 1 min. However, its some- 
Table 2. Kinetic Constants for Binding of I-EsHb and I-Edrdl-Hb to SEB and SEA’ 
Immo- Injected Association Dissociation 
bilized Injected Protein Rate Rate 
Protein Protein Cont. (pM) (IlmoWs) (4(x IV 
SEA I-Ed-Hb 1 3,400 f 80 2,000 f 8 
SEA I-Edr*-Hb 1 5,709 f 80 1,900 f 5 
SEB I-Edrdk-Hb 1 8o.ooo f 3,100 35,000 f 1.800 
a Derived from data in Figure 1. 
Dissociation 
Half-life Constant 
(min) (PM) 
8.33 f 0.03 0.58 i 0.02 
8.77 f 0.02 0.33 f 0.004 
0.48 f 0.02 0.39 f 0.02 
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Figure 2. Effect of Class II-Bound Peptide on Binding to SEA and 
SEB 
SEA (6,500 RU) and SEB (3,400 RU) were immobilized in biosenser 
flow cells. In (A), (B), and (C) I-Edh with the various peptides shown 
covalently attached (0.5 uM) were injected for 2 min (flow rate, 15 pll 
min) into the SEA flow cell and the binding kinetics recorded during 
the association and dissociation phases. In (D), a similar experiment 
was performed with the SEBflow cell using I-Edrdkoccupied with three 
of the peptides. For ease of comparison, the RU results are shown 
as the percent of the maximum RU signal at the end of the association 
phase. 
what faster association rate of 20,000 llmolls led to an 
apparent dissociation constant of about 1 PM, which was 
not much different from that seen with I-Edk-Hb. Nearly 
identical results were seen with I-Edrdk-Hsp70 binding to 
SEA (data not shown). 
Table 3. Effect of Peptide on Kinetic Constants for Binding of I-Edk and I-Edr* to SEB and SEA’ 
Immo- Injected- Association Dissociation 
bilized Injected Peptide Class II Rate Rate 
Protein Class II (Mutation) Cont. (t&f) (I/mol/s) (W (x 107 
SEA I-E” MCC 0.5 7,500 f 740 240 f 5 
SEA I-Edx PCC (TlO2S) 0.5 6,600 f 690 250 f 5 
SEA l-Ed’ MCC (K99A) 0.5 6,600 f 1,060 370 f 16 
SEA I-P* Hb 0.5 3,200 f 470 1,700 f 9 
SEA I-Edk Hb (K72A) 0.5 6,500 e 630 2,100 f 11 
SEA LEO* Hsp70 0.5 20,006 Et 1,600 19,000 f 210 
SEB I-Edrdk MCC 0.5 100,000 f 740 75,000 f 1,600 
SEB I-Edrdk Hb 0.5 160,000~690 66,000 f 2,900 
SEB I-EdrdX Hsp70 0.5 120,000 f 1,060 53,ooo f 1,320 
a Derived from data in Figure 2. 
Half-life 
(min) 
69.4 e 1.4 
66.7 f 1.3 
45.0 * 1.9 
9.6 f 0.1 
7.9 f 0.1 
0.66 f 0.01 
0.22 f 0.005 
0.25 f 0.011 
0.31 f 0.006 
Dissociation 
Constant 
w4 
0.031 f 0.003 
0.029 f 0.002 
0.055 f 0.009 
0.53 f 0.01 
0.33 Et 0.04 
0.95 f 0.01 
0.73 * 0.02 
0.36 f 0.02 
0.46 f 0.01 
Taken together, the simplest explanation for these re- 
sults is that the peptide bound to class II forms part of the 
SEA binding site. However, it is also possible that these 
peptides act indirectly by altering the orientation of class 
II amino acids involved in SEA binding (see Discussion). 
The relevant portion of the peptide probably lies in its N-ter- 
minal half, since substitutions in the reportedly upward- 
pointing amino acids of the C-terminal half of the peptides 
of I-Edk-MCC and I-Edk-Hb had no effect on SEA binding. 
Consistent with this idea is the finding that binding of SEA 
to class II can block accessibility by avidin to an class II- 
bound peptide biotinylated at the N terminus (Dowd et al., 
1995). 
To see whether the effects of these peptides on the 
binding of SEA were reflected in presentation of SEA to 
T cells, we immobilized three of the I-Edk molecules, I-Edk- 
MCC, I-Edk-Hb, and I-Edk-Hsp70, in plastic tissue culture 
wells and examined their abilities to present SEA to an 
SEA-reactive VfX3-bearing T cell hybridoma. The results 
are shown in Figure 3. As predicted by the relative dissoci- 
ation constants, I-Edk-MCC presented SEA much better 
than either I-Edk-Hb or I-Edk-Hsp70, confirming that the 
relative binding seen in the biosensor instrument reflected 
the formation of functional SEA-class II complexes. 
The results with the I-Edrdk molecules binding to SEB 
were again very different (see Figure 2D; Table 2). 
Whether occupied by the MCC, Hb, or Hsp70 peptide, this 
class II molecule associated rapidly with SEB (1-2 x lo5 
I/mol/s), as predicted by the lack of peptide SEB contacts 
in the crystal structure of the SEB-DRl complex. A large 
majority of these complexes also dissociated very rapidly 
at 0.05-0.08/s for half-lives of 20-30 s, leading to apparent 
dissociation constants of 0.4-0.7 urn. However, as before, 
a small portion of the complexes dissociated much more 
slowly, especially those containing the Hsp70 or Hb pep 
tides. This again may indicate a slower second order bind- 
ing reaction. 
Scatchard analysis has been used to estimate the disso- 
ciation constant for SEA binding to cell-bound or purified 
class II occupied by a full complement of natural peptides. 
A value of 1-5 uM was measured for I-Ed (Lee and Watts, 
1990). Similarly, for SEA binding to DRl values were 0.025 
PM for soluble purified DRl (Fraser et al., 1992) and 0.08 
Binding Sites for Superantigens on Class Ii MHC 
191 
1 A Cation Depleted SEA I 0 SEA 
l 
0 . 0.1 1.0 10 
SEA (ug/ml) 
Figure 3. Peptide Influence on Presentation of SEA to a V53+ T Cell 
Hybridoma 
Soluble I-Ed* molecules occupied with either MCC, Hb, or Hsp70 and 
immobilized by absorption to the surface of 95well plates were tested 
for their ability to present SEA to a Vf33’ T cell hybridoma cells (K25-49). 
The amount of IL-2 secreted by the hybridoma after 20 hr is shown 
versus the concentration of SEA added. 
pM for cell-bound DRl (Mollicket al., 1991). These experi- 
ments assumed a single homogeneous SEA binding site. 
Our results predict that this average binding affinity is a 
composite of a wide range, which depended on the particu- 
lar array of natural peptides bound to class II. Previous 
Scatchard estimates of dissociation constants for SEB 
binding to natural DRl are 0.24 pM for binding to cell- 
bound DRl (Mollick et al., 1991) and 1.7 pM for binding 
to purified DRl in a BlAcore system (Seth et al., 1994). 
Our values for single peptide I-Edrdk molecules are in this 
range (0.4-0.7 bM). 
Role of iW+ and Ej3H81 in SEA Binding 
to I-Edk-Peptide 
Fraser et al. (1992) have shown that SEA and the related 
SAgs, SEE and SED, have a Zn2+ cation incorporated into 
their structures coordinated by the histidines, which are 
unique in the C-terminal domains of these SAgs. Removal 
of this Zn2+ drastically reduces the binding of SEA to the 
HLA DRl class II molecule. To see whether the binding 
we observed between the soluble mouse class II-peptide 
proteins and SEA was also Zn2+ dependent, we immobi- 
lized SEA in a biosensor flow cell and included 10 uM 
EDTA in the instrument running buffer to remove any diva- 
lent cations bound to the SEA. We then attempted to bind 
I-Edk-Hb to this cation-depleted SEA. The results are 
shown in Figure 4A. 
When the class II molecule was introduced in the same 
EDTA-containing running buffer, no significant binding to 
SEA was seen. However, if excess (15 pM) Zn2+ was in- 
cluded in the injection sample, normal binding to SEA was 
seen. This cation requirement could not be met by Caz+ 
or Mg’+. Weak but significant binding was seen with Cu2+ 
and even weaker binding with NP+. Similar results were 
seen with the other I-Edk-peptide constructs (data not 
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Figure 4. Importance of Znh and I-E5H91 for SEA Binding to 1-E”’ 
(A) SEA was immobilized in a biosenser flow cell (8,500 RU) and 
washed thoroughly with running buffer containing 10 t.rM EDTA to 
remove associated divalent cations. With the same EDTA containing 
running buffer, aliquots of I-Ed’-Hb (1 PM) were injected for 2 min in 
the same buffer with or without each of the various divalent cations 
shown at 15 uM, such that the cations were present only during the 
association phase. 
(6) SEA was immobilized in a biosenser flow cell (9,500 RU) and either 
I-Ed’-Hb or I-Ed”-Hb(f3HBlY) (1 FM) injected for 2 min. 
shown). In other control experiments, we established that 
I-Edk-Hb did not bind in the presence of Zn% in a biosenser 
flow cell to which no SEA had been coupled and that the 
presence or absence of Zn2+ had no effect on I-Edrdk bind- 
ing to SEB (data not shown). 
Mutation of the conserved histidine at position 81 of the 
class II 8 chain severely reduces SEA binding and presen- 
tation to T cells (Herman et al., 1990, 1991; Jorgensen et 
al., 1992). This amino acid has been suggested to act by 
providing an additional coordination group for Zn% during 
SEA binding (Hudson et al., 1995). Therefore, we tested 
its role in the binding of I-Edk to SEA, by introducing a 
mutation in this position (8H81Y) in several of the I-Edk 
molecules (see Table 1) and testing these for their ability 
to bind to SEA. The results with I-Edk-Hb(H81Y) are shown 
compared with those with I-Edk-Hb in Figure 48. The bind- 
ing kinetics of I-Edk-Hb were very similar to those pre- 
sented in Figures 1 and 2. As predicted, the binding of 
SEA was nearly eliminated by the H81Y mutation. To- 
gether, these results strengthened our conclusion that the 
binding seen with this instrumentation reflects the proper- 
ties of the SEA binding to natural cell-bound class II. 
Class II Epitopes Lost upon SEA Binding to I-Edk 
To define the site of SEA/I-Edk interaction further, we deter- 
mined which anti-l-E MAb epitopes were lost when the 
SEA-class II complex was formed. The results of these 
experiments are shown in Figure 5. As before, SEA was 
immobilized in the instrument flow cell and stable long- 
lived SEA-class II complexes were formed by injecting 
soluble I-Edk-MCC. By forming the complexes in this way, 
we assured that all of the I-Edk-MCC captured in the flow 
cell wasoccupied with SEA. During thedissociation phase 
of the experiment, we injected a series of MAbs specific 
for epitopes on either the al or 81 domain of the I-E mole- 
A Immobilized SEA 
B Immobilized 17-3-3 (anti-p) 
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Figure 5. Both al and 51 Epitopes Are Lost from I-Edk Upon SEA 
Binding 
(A) SEA was immobilized in a biosenser flow cell (4,000 RU). In two 
different experiments, I-Edk-MCC (1 uM) was injected for 2 min (flow 
rate, 15 ukml) to establish SEA/I-Edh-MCC complexes. This was fol- 
lowed during the dissociation phase with 2 min iniections at intervals 
of 0.5 PM MAb in the following order: M5H 14, then 1444, and then 
either 17-3-3 or Y 17. 
(B) MAb 17-3-3 was immobilized in a biosenser flow cell (9,300 RU). 
I-Ed”-MCC (ImM) was injected for 2 min (flow rate, 15 ullmin) to estab- 
lish I-Edk-MCCII 7-3-3 complexes. This was followed during thedissoci- 
ation phase with 2 min injections at intervals of 0.5 uM MAb in the 
following order: Y17, then M5/114, and then 14-4-4. 
(C) The backbone of the al and 51 domains of DRI (Brown et al., 
1993; Stern et al., 1994) is shown as a model for I-Edk. The approximate 
locations of MAb epitopes are shown with some of their key features. 
On the a chain, amino acids 136, E37, and S39 are labeled, since 
mutation of these amino acids to the corresponding amino acids of 
DRI results in loss of the 144-4 epitope. On the (3 chain, amino acid 
R49 on b strand 4 is labeled because mutation of this amino acid 
cule with the rationale that, if the site of SEA binding over- 
lapped or blocked the MAb epitope, no MAb binding 
should be seen. The results are shown in Figure 5A. 
Neither 1444 (anti-Ea) nor MU1 14 (anti-ED) bound to the 
SEA/I-Edk-MCC complex formed in this way in agreement 
with previous studiesshowing the inhibition of SEA binding 
to and presentation by I-E molecules by these MAbs (Lee 
and Watts, 1990; Yagi et al., 1990). Two other anti-l-E 
MAbs, Y17 and 17-3-3, continued to bind strongly. The 
ability of 14-44 and M5/114 to bind to I-Edk-MCC in the 
absence of SEA was established in a separate experiment 
in which I-Edk-MCC, captured in the flow cell by immobi- 
lized 17-33, was shown to bind 1444 and M5/114, but not 
Y17 (whose epitope overlaps with 17-3-3) subsequently 
injected (Figure 5B). The approximate location of the epi- 
topes detected by these antibodies are shown in Figure 
5C. These results indicate that the site of SEA binding to 
I-Edk either overlaps or sterically blocks epitopes on both 
the al and pl domains of class II and again suggest a 
binding site near the N terminus of the class II-bound 
peptide. 
Simultaneous Binding of SEA and SEB to I-Edrdk 
Taken together, our results indicated that SEA and SEB 
bind to class II in very different ways. Therefore, in a final 
experiment we examined the ability of these SAgs to inter- 
fere with each other in their binding to I-Edrdk. We immobi- 
lized SEA in the instrument flow cell and injected either 
I-Edk-MCC or I-Edrdk-MCC to form, as above, long-lived 
stable complexes with all molecules of class II in the flow 
cell occupied with SEA. We then injected SEA followed 
by SEB to see whether either toxin could find a site to 
bind to class II molecule already occupied with SEA. The 
results are shown in Figure 6. As expected, neither com- 
plex was able to bind additional SEA, confirming that in 
capturing the class II, the immobilized SEA occupied all 
SEA bind sites. However the SEA/I-Edrdk-MCC complex, 
but not the SEA/I-Edk-MCC complex, was able to bind 
SEB, showing that a single molecule of I-Edrdk-MCC was 
able to bind both SAgs simultaneously. 
Discussion 
The binding of toxin superantigens to class II has been 
studied with both cell-bound and soluble molecules occu- 
pied with a normal array of different peptides. Our experi- 
ments examine SEA and SEB binding to soluble class II 
molecules occupied with single peptides, measure kinetic 
results in loss of 17-3-3 epitope. Also on the 5 chain, amino acid P65 
is marked because a deletion of 1 aa at this point is common to the 
mouse class II molecules that lack the M5/114 epitope. In addition, 
since the M5/114 epitope is shared between mouse I-E and I-A class 
II isotypes, thesurface-exposed 5chain aminoacids in thisarea, which 
are identical between M5/114 reactive I-A and I-E molecules, are col- 
ored black. Details of the data concerning these epitopes are dis- 
cussed in Experimental Procedures. This figure was prepared using 
the RasWin version of RasMol (R. Sayle, Glaxo Research and Develop 
ment, Greenford, Middlesex, England). 
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Figure 6. Simultaneous Binding of SEA and SEB lo I-Edrdk-MCC 
(A) SEA was immobilized in a biosenser flow chamber (3,500 RU). 
I-Ed’-MCC (1 PM) was injected for 2 min (flow rate, 15 pllmin) to estab- 
lish SEA/I-Edh-MCC complexes. This was followed during the dissocia- 
tion phasewith an inject of SEA(2 pMfor 2 min)followed by an injection 
of SEB (2 pM for 2 min) at the same flow rate. 
(6) Same as in (A), but with I-Edr dk-MCC instead of I-E’WKC. 
association and dissociation rates, and examine directly 
the binding sites for different SAgs on the same class II 
molecule. Our results show that SEB and SEA have very 
different interactions with class II. 
Our results with SEB were consistent with previous mu- 
tational studies of SEB (Kappler et al., 1992) and the pub- 
lished crystal structures of SE6 (Swaminathan et al., 1992) 
and of an SEBIHLA-DRl complex (Jardetzky et al., 1994). 
These revealed an interaction between the SEB N-ter- 
minal domain and the a chain of class II (Figure 7). In our 
experiments, we observed a large improvement in binding 
when we made several amino acid substitutions in the 
I-E a chain, introducing HLA DR residues known to be 
important in this SEB binding site. In addition, a mutation 
(F44S) in SEB, which had been shown to reduce severely 
binding of SEB to cell-bound DR and lie at the core of this 
interaction site (Figure 7), also eliminated the binding of 
I-Edrdk. Finally, also as predicted by the crystal structure, 
we observed little effect of the class II-bound peptide on 
the binding of I-Edrdk to SEB. Our kinetic studies indicated 
a similarly fast association of I-Edr” to SEB (l-2 x 10s 
I/mol/s), regardless of the class II-bound peptide. In each 
case, the majority of class II also dissociated rapidly(0.05- 
0.07/s) with a small portion dissociating more slowly. 
Our results with SEA defined a different site of interac- 
tion with I-Edk. The binding was very dependent on the 
presence of Zn2+ in the SEA and on H81 in the B chain a 
helix. The I-Edk-bound peptide had a profound effect on 
the binding kinetics, especially on dissociation rates. The 
half-lives of the complexes varied from under 1 min to over 
1 hr depending on the particular peptide carried by I-Edk. 
MAb epitopes on both the al and fll chain of I-E* were 
lost upon SEA binding. The a chain epitope was mapped 
to the portion of the al domain near the N terminus of the 
class II-bound peptide. The a chain amino acid substitu- 
tions that greatly improved I-E” binding to SEB had no 
effect on binding to SEA. Perhaps most revealing was the 
observation that a single I-Ed+ molecule could bind a 
molecule of SEA and SEB simultaneously. 
Taken together, the results support a model in which 
Figure 7. Proposed Site(s) of SEA Binding to 
l-l? 
Three crystal structures (flu peptidelDR1 
[Stern et al., 19941, SEB/DRl [Jardetzky et al., 
19941, and SEB [Swaminathan et al., 19921) 
were superimposed (Insight II by Biosym, San 
Diego, California) to construct a model for SEB 
bound lo I-E. The backbone of the al (magenta) 
domain, 61 (cyan) domain, and peptide (white) 
are shown. The position of conserved amino 
acid BHis61 is shown in yellow. The backbone 
of a SEB is shown with the N-terminal domain 
of (amino acids 32-124) colored dark green 
and the other mostly C-terminal domain (amino 
acids l-31 plus amino acids 125-239) colored 
light green. The position of two SEB amino 
acids (F44, L45) that form part of the core of 
the class II a chain binding site are colored 
orange. Also shown is a model for SEA based 
on the SEB crystal structure. The backbone is 
shown using the same coloring scheme as for 
SEB. The positions of SEB amino acids 1190 
and K229 are shown in red corresponding to 
SEA H167 and H225. Also on the SEA model, 
shown in blue, are the positions of SEB N23, 
Q210, and S211, which correspond to SEA 
N25, 5206, and N207. The modeled SEA is 
shown in a proposed interaction orientation 
with the I-E molecule. (See text for discussion). 
This figure was prepared using the program 
Ribbons by M. Carson, University of Alabama, 
Birmingham, Alabama. 
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SEA binds over one end of the class II molecule (Figure 7). 
This orientation allows interaction between an SEA-bound 
Zn*+ and class II PH81, and is consistent with the blocking 
of MAb epitopes on both al (14-4-4) and pl (M5/114). It 
also suggests two ways in which the class II-bound pep- 
tide might influence SEA binding. First, amino acids from 
the N-terminal portion of the peptide in or extending from 
the end of the peptide groove may interact directly with 
SEA. Second, since the crystal structure of an influenza 
peptide bound to DRl (Stern et al., 1994) shows that the 
side chain of PH81 interacts with the peptide backbone, 
this side chain may be more or less available for interaction 
with SEA, depending on how involved it is with the binding 
of a particular peptide. Finally, this orientation of the SEA 
molecule does not interfere with the predicted SEB inter- 
action site and preserves the upward orientation of the 
SEA amino acids that are important in TCR interaction 
(Hudson et al., 1993). 
This model is not consistent with all data on SEA binding 
to class II. For example, SEA competes with SEB for bind- 
ing to HLA-DR-expressing cells (Fraser, 1989; Thibodeau 
et al., 1994a). Furthermore, mutations in the predicted 
N-terminal domain diminish its ability to bind to class II- 
bearing cells and be presented to T cells (Harris et al., 
1993; Scherer et al., 1993, Hudson et al., 1995). These 
results suggest that a binding site similar to that seen in 
the SEBlDRl crystal structure contributes to SEA binding 
to and presentation by some class II in some cases. 
Perhaps the resolution of this paradox is that SEA can 
bind to class II in two ways, a major site, as we propose 
here, and a secondary site similar to that seen in the SEBl 
DRl crystal (Figure 7). Possibly the affinity of SEA is very 
low for this second site on I-Ed” compared with HLA-DR 
and, therefore, was not revealed in our binding studies. 
In support of this view, we have found in preliminary stud- 
ies that mutation of L47 (Scherer et al., 1993) in SEA, which 
diminishes its binding and presentation by DR expressing 
cells, does not affect the binding of our soluble I-Edk mole- 
cules to SEA (data not shown). 
We have discussed this potential for two interaction sites 
on SAg for class II previously (Kappler et al., 1992; Scherer 
et al., 1993), since it raises the possibility that a single 
molecule of SAg may bridge two class II molecules. If, in 
fact, the defined SEB-DRl interaction in Figure 7 is a 
model for a second SEA-class II interaction, one could 
propose the formation of larger “daisy chain” oligomers, 
since the two sites appear to be noncompeting on either 
SEA or class II. The formation of these surface aggregates 
either before or during interaction with T cells could be 
expected to increase dramatically the efficiency of SAg 
presentation. A similar argument has been made by Hud- 
son et al. (1995). 
These data have implications for hypotheses on the way 
in which the aPTCR recognizes SAgs bound to class II. 
One prominent idea has been that SAgs take advantage 
of the natural affinity of aPTCRs for class II, such that 
the same type of alignment of the TCR over the class II 
molecule is preserved during SAg interaction (Janeway 
et al., 1989). Although the data at present do not exclude 
apTCR-class II interactions during SEA presentation, they 
would seem to preclude the same geometry of interaction 
as seen during peptide antigen recognition, since the SEA 
binding site appears to involve a considerable portion of 
the class II a helices and bound peptide. 
If the role of class II in SEA presentation is then simply 
to bind SAg in the correct orientation for interaction with 
the TCR, one could ask why all SAgs use class II for this 
function, when any other surface molecule could conceiv- 
ably serve the same function. The answer may be related 
to the unique distribution of class II on antigen-presenting 
cells that have the other ligands and functions required 
for productive T cell activation. 
Experimental Procedures 
Construction and Productlon of Soluble Clacu, II Molecules 
As previously described (Kozono et al., 1994), we used baculovirus- 
infected insect cells to produce soluble I-Edk molecules with peptides 
linked to their p chain N termini via flexible linkers. In brief, truncated 
I-Ead and I-ED’ genes were cloned into a modified version of the transfer 
plasmid, pAcUW51. In addition to the original MCC peptide, five new 
peptides, MCC-K99A, PCC-Tl02S, Hb, HbN72A, and Hsp70 (Table 
1) were introduced by digestion of the plasmid with Xmal and Spel to 
remove the region encoding the MCC peptide, followed by ligation of 
oligonucleotides encoding the new peptides. Also, except for MCC 
and Hsp70, the thrombin site, LVPRGS. in the middle of linker was 
replaced with LVGGGS by using oligonucleotidea to change the DNA 
sequence between the Spel site at the junction between the peptide 
and the linker and the Ncol site at the beginning of I-EBI domain. 
Additional versions of the MCC, Hb, and Hsp70 constructs were made 
by using the polymerase chain reaction to change three amino acids 
in the al domainoftheachain(l36, E37, andS39)to thecorresponding 
amino acids in DRI (M, A, and K, respectively). These molecules are 
referred to as I-Ed@. Finally, for the MCC and Hb peptides, constructs 
were made using the polymerase chain reaction to synthesize a frag- 
ment of the ED’; gene containing the mutation, bH61 Y (CAC - TAT). 
The fragment was cloned into the constructs between the Ahall and 
Bglll sites of the B gene. 
The constructions were introduced into baculovirus by recombina- 
tion during cotransfection into SF9 insect cells with Baculogold DNA 
(Pharmingen) as previously described (Kozono et al., 1994). High 
titered (2-5 x IOU pfu/ml), cloned, recombinant virus stocks were pre- 
pared. High5 insect cells (Invitrogen) were used for scaled-up protein 
production. The cells were grown nearly to confluenge in TNM-FH, 
then infected at a multiplicity of infection of 5-10 in CCM3 serum-free 
media (GIBCO BRL). After 6 days, supernatants containing the se- 
creted recombinant proteins were harvested and purified by immu- 
noaffinity chromatography using the anti-class II MAbs, 144-4 (anti- 
Ea) for l-Ed’ molecules and 17-3-3 (anti-ED) for I-Edrdh. Class II proteins 
were eluled by 50 mM carbonate (pH 10.5), then neutralized and con- 
centrated using Centricon 30 concentrators (Amicon, Beverfey, Mas- 
sachusetts). The integrity of the class II proteins were tested in three 
ways: SDS-PAGE, size exclusion column chromatography, and, when 
available, T cell hybridoma activation. Class II proteins were stored 
at 4OC in phosphate-buffered saline with 0.02% NaN,. 
Superantigens 
SEA was purchased from Toxin Technology, Incorporated (Sarasota, 
Florida). Recombinant SEB was made as previously described (Kap 
pler et al., 1992). 
MAbs 
We used 4 MAbs to characterize SEA/I-Edk and SEA/I-E* complexes: 
one anti-al, 14-4-4 (Ozato et al., 1960); and three anti-61, M5/114 
(Bhattacharyaetal., 1961), 1733(Ozatoetal., 1960),andYl7(Lerner 
et al., 1960). The approximate locations of the epitopes for these MAbs 
(Figure 5C) were deduced by their class II allele and isotype specificity, 
sensitivity to I-E amino acid substitutions, and ability to compete with 
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each other for binding to I-Edk in experiments such as that described 
in Figure 58. Summarizing the data for each MAb: 
14.4.4 
This MAb defines epitope la.7 on all I-E a chains. Its epitope is de- 
stroyed by introducing three al aminoacidssubstitutions(l36M, E37A, 
and S39K, see above) on the loop between 6 strands 3 and 4 and this 
MAb does not compete for binding to I-Edk with any of the other MAbs 
(Figure 58; data not shown). 
MSll14 
This MAb is crossreactive with I-E and certain I-A class II alleles. All 
I-E and I-A molecules have a large region of identity in solvent exposed 
areas of the 61 a helix and 6 sheet loops (Figure 5C). Lack of reactivity 
with M5/114 is associated with a 1 aa deletion at position 65 in some 
I-A alleles. This MAb does not compete for binding to l-Ed” with any 
of the other MAbs (Figure 58; data not shown). 
17-3-3 
This MAb competes with Y17, but not with 1444 or M5/114, for binding 
to I-Edk (Figure 58; data not shown). Its epitope is destroyed by the 
mutation 6R46H (Griffith et al., 1967) but not by replacement of the 
Ea chain with DRa (Barber and Lechler, 1991). 
Y17 
This MAb competes with 17-3-3, but not with 14-4-4 or M51114, for 
binding to I-Edk (Figure 58; data not shown). This epitope is not affected 
by mutation 6R46H (Griffith et al., 1967). Its allele distribution is the 
same as 17-3-3, mapping it to the 6 chain, but it is lost upon replace- 
ment of the Ea chain with DRa (Barber and Lechler, 1991) suggesting 
an influence of a6 chain association. 
Measurements of Protein-Protein Binding 
Protein interactions were monitored using the BlAcore system (Phar- 
macia). SAgs and MAbs were diluted in 10 mM acetate buffer (pH 5.0) 
to a concentration of 50 rig/ml and immobilized in the flow cell of a 
biosenser chip, CM5 (Pharmacia). using N-hydroxysuccinimide and 
N-ethyl-N’-(3-dimethyl-aminopropyl)-carbodiimide hydrochloride. Un- 
less otherwise stated, HEPES-buffered saline (10 mM HEPES, 150 
mM NaCI, and 2 mM ZnClr, 0.05% surfactant P20 [pH7.4]) was used 
as the standard running buffer. Analytes were usually injected with 
volume of 30 ~1 with flow rate of 15 nllmin. The amount of immobilized 
ligand (resonance units [RU]) and flow rate were indicated in each 
figure legend. Regeneration of the flow cells with immobilized SAg 
was accomplished either by an extended wash with EDTA containing 
HEPES-buffered saline or by the injection of 50 mM carbonate (pH 
10.5) followed by 1 mM ZnC12 or corn bination of both methods. Associa- 
tion and dissociation rates were calculated from RU data by the BIA- 
evalutions2 program based on the methods of O’Shannessy et al. 
(1993). 
T Cell Hybridoma Activation Assay 
The wells of Immulon4 ELISA plates (Dynatech, Virginia) were incu- 
bated with purified class II molecules (500 rig/well) in phosphate- 
buffered saline overnight. The coated wells were washed twice with 
tissue culture medium supplemented with 10% fetal calf serum. SEA 
was added at various concentrations with 10s K25-49 cells, a V63+ T 
cell hybridoma (Pullen et al., 1966). After 20 hr culture, supernatants 
were assayed for IL-2 as described previously (Kappler et al., 1961; 
Mosmann, 1963). 
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